ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
126 hedge funds and large institutions have $676M invested in Adamas Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+8
Holders Change %
+6.78%
% of All Funds
2.89%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
22
Increased
54
Reduced
33
Closed
13
Calls
$8.34M
Puts
$6.37M
Net Calls
+$1.98M
Net Calls Change
+$832K
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$28M |
| 2 |
2
BlackRock
New York
|
$47.7M |
| 3 |
BC
3
Broadfin Capital
New York
|
$36.6M |
| 4 |
SI
4
Sofinnova Investments
Menlo Park,
California
|
$7.32M |
| 5 |
5
Millennium Management
New York
|
$8.84M |
